Total raised
$60.0M
Last: Debt Financing 2024-07
Stage
Acquired
Founded
2009
Headcount
59
HQ
Herzliya, Israel
Sector
—
About
Endospan developed low-profile stent graft systems for treating aneurysms and dissections throughout the aorta, including infrarenal, visceral, and thoracic. Its NEXUS Aortic Arch Stent Graft System received FDA approval in April 2026, leading to its acquisition by Artivion, Inc. in May 2026 for a base price of $175 million, with potential for up to an additional $200 million contingent on commercial performance. The company's innovative platform aimed to make the treatment of aortic lesions simpler and less invasive, offering solutions for patients with limited treatment options. Endospan was headquartered in Herzliya, Israel.
Funding history · 4 rounds · $60.0M total
2024-07
Debt Financing
$25.0M
2019-09
Undisclosed
$10.0M
2019-09
Debt Financing
$15.0M
2015-10
Series B
$10.0M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Endospan founded and where was it headquartered?
- Endospan was founded in 2009 and was headquartered in Herzliya, Israel.
- What was Endospan's primary product or technology?
- Endospan developed low-profile stent graft systems for treating aneurysms and dissections throughout the aorta, including infrarenal, visceral, and thoracic.
- What was a significant regulatory milestone for Endospan's NEXUS Aortic Arch Stent Graft System?
- Endospan's NEXUS Aortic Arch Stent Graft System received FDA approval in April 2026.
- When and by whom was Endospan acquired?
- Endospan was acquired by Artivion, Inc. in May 2026.
- What was the initial acquisition price for Endospan?
- Endospan was acquired for a base price of $175 million, with potential for up to an additional $200 million contingent on commercial performance.
- Which investors participated in Endospan's Series B round in October 2015?
- Accelmed and Sequoia Capital were among the investors in Endospan's Series B round in October 2015.
- What was Endospan's last recorded funding round prior to its acquisition?
- Endospan secured a Debt Financing round of $25 million in July 2024, with Artivion as a lead investor.
- What was the total amount of funding Endospan raised?
- Endospan raised a total of $60 million in funding. For a full financing history, please refer to startupim.
- How many employees did Endospan have at the time of its acquisition?
- Endospan had 59 employees at the time of its acquisition.
Team · 6
Kevin Mayberry
CEO
Alon Shalev
Founder · Founder
Rafi Benary
Founder · Co-Founder
Ami Katz
VP Operations & Engineering
Asher Zilberstein
VP QA/RA
Pieter Buyl
Vice President Sales & Marketing
Sectors & technology
Target customers
Business model
B2B
Highlights
undefined Patents
Tags
surgeonsvascularmedical-devicescardiovascularstentsurgerycardiology